Banzai Announces $20.3 Million Debt Repayment Ahead of Schedule
Fully Satisfies Outstanding Debt Obligations to Key Vendors and Delivers Material Benefit to Net Income and Shareholders’ Equity SEATTLE, April […]
HomesToLife Ltd Announces Financial Results for Fiscal Year 2024; Company to hold Conference Call to Discuss Results April 11 at 8:30 am ET
SINGAPORE, April 07, 2025 (GLOBE NEWSWIRE) — HomesToLife Ltd (NASDAQ: HTLM) (“HomesToLife” or the “Company”), the holding company of one of the […]
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming […]
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
RA’ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (“Inspira” or the “Company”), […]
Blue Hat Regains Compliance with Nasdaq Minimum Bid Price Requirement
XIAMEN, China, April 07, 2025 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), […]
Alico to Present at the Planet Microcap Showcase: VEGAS 2025
FORT MYERS, Fla., April 07, 2025 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that […]
Red Cat Appoints Shawn Webb as President of FlightWave Aerospace
SANTA MONICA, Calif., April 07, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), […]
SEALSQ and WISeSat to Showcase Breakthrough Post-Quantum Satellite Technology at the 40th Annual Space Symposium in Colorado Springs
Geneva, Switzerland, April 07, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on […]
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 […]
HeartCore Announces Strategic Partnership with NEC Solution Innovators, Ltd. to Enhance CMS Implementation Process
NEW YORK and TOKYO, April 07, 2025 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a […]
